Literature DB >> 35896619

Longitudinal trajectories of cortical development in 22q11.2 copy number variants and typically developing controls.

Maria Jalbrzikowski1,2, Amy Lin3,4, Ariana Vajdi3, Vardui Grigoryan3, Leila Kushan3, Christopher R K Ching5, Charles Schleifer3,4, Rebecca A Hayes6, Stephanie A Chu3,4, Catherine A Sugar3,7, Jennifer K Forsyth3,8, Carrie E Bearden9,10,11.   

Abstract

Probing naturally-occurring, reciprocal genomic copy number variations (CNVs) may help us understand mechanisms that underlie deviations from typical brain development. Cross-sectional studies have identified prominent reductions in cortical surface area (SA) and increased cortical thickness (CT) in 22q11.2 deletion carriers (22qDel), with the opposite pattern in duplication carriers (22qDup), but the longitudinal trajectories of these anomalies-and their relationship to clinical symptomatology-are unknown. Here, we examined neuroanatomic changes within a longitudinal cohort of 261 22q11.2 CNV carriers and demographically-matched typically developing (TD) controls (84 22qDel, 34 22qDup, and 143 TD; mean age 18.35, ±10.67 years; 50.47% female). A total of 431 magnetic resonance imaging scans (164 22qDel, 59 22qDup, and 208 TD control scans; mean interscan interval = 20.27 months) were examined. Longitudinal FreeSurfer analysis pipelines were used to parcellate the cortex and calculate average CT and SA for each region. First, general additive mixed models (GAMMs) were used to identify regions with between-group differences in developmental trajectories. Secondly, we investigated whether these trajectories were associated with clinical outcomes. Developmental trajectories of CT were more protracted in 22qDel relative to TD and 22qDup. 22qDup failed to show normative age-related SA decreases. 22qDel individuals with psychosis spectrum symptoms showed two distinct periods of altered CT trajectories relative to 22qDel without psychotic symptoms. In contrast, 22q11.2 CNV carriers with autism spectrum diagnoses showed early alterations in SA trajectories. Collectively, these results provide new insights into altered neurodevelopment in 22q11.2 CNV carriers, which may shed light on neural mechanisms underlying distinct clinical outcomes.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 35896619     DOI: 10.1038/s41380-022-01681-w

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   13.437


  60 in total

Review 1.  CNVs: harbingers of a rare variant revolution in psychiatric genetics.

Authors:  Dheeraj Malhotra; Jonathan Sebat
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

2.  Lessons to be Learned From 22q2.11 Syndromes-Reply.

Authors:  Louise K Hoeffding; Carsten B Pedersen; Thomas Werge
Journal:  JAMA Psychiatry       Date:  2017-07-01       Impact factor: 21.596

3.  Low copy repeats mediate distal chromosome 22q11.2 deletions: sequence analysis predicts breakpoint mechanisms.

Authors:  Tamim H Shaikh; Ronald J O'Connor; Mary Ella Pierpont; James McGrath; April M Hacker; Manjunath Nimmakayalu; Elizabeth Geiger; Beverly S Emanuel; Sulagna C Saitta
Journal:  Genome Res       Date:  2007-03-09       Impact factor: 9.043

Review 4.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

Review 5.  Schizophrenia and 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Eva W C Chow
Journal:  Curr Psychiatry Rep       Date:  2008-04       Impact factor: 5.285

Review 6.  Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders.

Authors:  N Hiroi; T Takahashi; A Hishimoto; T Izumi; S Boku; T Hiramoto
Journal:  Mol Psychiatry       Date:  2013-08-06       Impact factor: 15.992

7.  Synaptic and Gene Regulatory Mechanisms in Schizophrenia, Autism, and 22q11.2 Copy Number Variant-Mediated Risk for Neuropsychiatric Disorders.

Authors:  Jennifer K Forsyth; Daniel Nachun; Michael J Gandal; Daniel H Geschwind; Ariana E Anderson; Giovanni Coppola; Carrie E Bearden
Journal:  Biol Psychiatry       Date:  2019-07-11       Impact factor: 13.382

8.  Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome.

Authors:  Tamar Green; Doron Gothelf; Bronwyn Glaser; Martin Debbane; Amos Frisch; Moshe Kotler; Abraham Weizman; Stephan Eliez
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-11       Impact factor: 8.829

9.  Neuropsychiatric disorders in the 22q11 deletion syndrome.

Authors:  L Niklasson; P Rasmussen; S Oskarsdóttir; C Gillberg
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

Review 10.  Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.

Authors:  Maude Schneider; Martin Debbané; Anne S Bassett; Eva W C Chow; Wai Lun Alan Fung; Marianne van den Bree; Michael Owen; Kieran C Murphy; Maria Niarchou; Wendy R Kates; Kevin M Antshel; Wanda Fremont; Donna M McDonald-McGinn; Raquel E Gur; Elaine H Zackai; Jacob Vorstman; Sasja N Duijff; Petra W J Klaassen; Ann Swillen; Doron Gothelf; Tamar Green; Abraham Weizman; Therese Van Amelsvoort; Laurens Evers; Erik Boot; Vandana Shashi; Stephen R Hooper; Carrie E Bearden; Maria Jalbrzikowski; Marco Armando; Stefano Vicari; Declan G Murphy; Opal Ousley; Linda E Campbell; Tony J Simon; Stephan Eliez
Journal:  Am J Psychiatry       Date:  2014-06       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.